Oral Levothyroxine Treatment in Lithium Intoxication- Induced Myxedema Coma: A Case Report.

lithium intoxication myxedema coma oral administration thyroxine

Journal

Journal of acute medicine
ISSN: 2211-5587
Titre abrégé: J Acute Med
Pays: China (Republic : 1949- )
ID NLM: 101574304

Informations de publication

Date de publication:
01 Jun 2021
Historique:
received: 08 04 2020
revised: 08 07 2020
accepted: 21 07 2020
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 24 7 2021
Statut: ppublish

Résumé

Lithium intoxication-induced myxedema coma, a rare but dangerous condition of severe hypothyroidism, can be easily misdiagnosed in patients without history of hypothyroidism. The objective of this case report is to describe a lithium-treated patient who presented to emergency department with obtundation and moderate hypothermia and was diagnosed with myxedema coma and lithium toxicity. A 64-year-old female presented to the emergency department with obtundation and hypothermia. The patient had the past history of stage-III chronic kidney disease, bipolar-type schizoaffective disorder, hypertension, and hyperlipidemia, and she had received long-term lithium therapy for the schizoaffective disorder. Bradycardia with hypotension developed after a few hours of admission and thyroid function revealed thyroid-stimulating hormone 53.1 nIU/mL and free T4 (FT4) 0.11 ng/dL, and the serum lithium level was 2.54 mmol/L. Therefore, diagnosis of lithium intoxication-induced myxedema coma was made, and the patient was managed with oral form of levothyroxine (LT4) (loading dose of 400 mcg followed by 100 mcg per day), intensive fluid therapy, empirical antibiotics, mechanical ventilation, and inotropic agents; lithium had been discontinued since admission. The patient weaned from the mechanical ventilation and inotropic support at day 4 of admission and by day 6, the patient's consciousness had fully recovered; on day 9, the serum lithium level was 0.37 mmol/L. The patient's FT4 recovered to the normal range (0.96 ng/dL) on day 15. In patients with no history of hypothyroidism or neck surgery and radiation therapy, lithium intoxication can be the single contributor to myxedema coma, which can be treated with oral form of LT4 as thyroid replacement therapy with instant and intensive supportive care. However, further study is needed to compare the outcomes of the patients with myxedema coma treated by oral and intravenous LT4.

Identifiants

pubmed: 34295637
doi: 10.6705/j.jacme.202106_11(2).0004
pmc: PMC8238685
doi:

Types de publication

Case Reports

Langues

eng

Pagination

68-71

Informations de copyright

Copyright © 2021 by Taiwan Society of Emergency Medicine & Ainosco Press. All Rights Reserved.

Déclaration de conflit d'intérêts

The author declares that he has no competing interests.

Références

J Emerg Med. 1990 Jan-Feb;8(1):63-6
pubmed: 2191030
Am J Med. 1989 Sep;87(3):355-6
pubmed: 2773973
Indian J Endocrinol Metab. 2013 Dec;17(Suppl 3):S654-6
pubmed: 24910829
Crit Care. 2008;12(1):R1
pubmed: 18173846
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Thyroid. 1999 Dec;9(12):1167-74
pubmed: 10646654

Auteurs

Po-Hsuan Kao (PH)

National Taiwan University Hospital Department of Emergency Medicine Taipei Taiwan.

Classifications MeSH